Serum amyloid A and high-density lipoprotein cholesterol: serum markers of inflammation in sarcoidosis and other systemic disorders

Eur J Clin Invest. 2001 Dec;31(12):1070-7. doi: 10.1046/j.1365-2362.2001.00913.x.

Abstract

Hypocholesterolemia has been observed in several inflammatory diseases such as rheumatoid arthritis, myeloproliferative disorders, systemic lupus erythematosus and sarcoidosis. Serum amyloid A is an acute-phase reactant that is related to the high-density lipoprotein cholesterol. This review discusses the relationship between the activation of the cells of the monocyte-macrophage system, determined by the serum amyloid A levels, and the lipid metabolism, measured as alterations in plasma lipoprotein concentrations. The mechanisms of this association during acute inflammation are also discussed in this review.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Apolipoproteins / blood*
  • Arthritis, Rheumatoid / blood
  • Arthritis, Rheumatoid / immunology
  • Biomarkers
  • Cholesterol, HDL / blood*
  • Humans
  • Lupus Erythematosus, Systemic / blood
  • Lupus Erythematosus, Systemic / immunology
  • Myeloproliferative Disorders / blood
  • Myeloproliferative Disorders / immunology
  • Sarcoidosis / blood*
  • Sarcoidosis / immunology*
  • Serum Amyloid A Protein

Substances

  • Apolipoproteins
  • Biomarkers
  • Cholesterol, HDL
  • Serum Amyloid A Protein